Victory Capital Management Inc Kronos Bio, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$3.12 - $7.52 $370,780 - $893,676	-118,840 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$6.26 - $14.42 $7.43 Million - $17.1 Million	-1,186,799 Reduced 90.9%	118,840 $859,000
Q4 2021 Feb 07, 2022	BUY	$11.35 - $21.18 $453,341 - $845,971	39,942 Added 3.16%	1,305,639 $17.7 Million
Q3 2021 Nov 02, 2021	BUY	$18.17 - $24.7 $3.01 Million - $4.09 Million	165,617 Added 15.05%	1,265,697 $26.5 Million
Q2 2021 Aug 03, 2021	BUY	$20.08 - $29.02 $823,561 - $1.19 Million	41,014 Added 3.87%	1,100,080 $26.3 Million
Q1 2021 May 04, 2021	BUY	$27.0 - $32.48 $10.6 Million - $12.8 Million	392,629 Added 58.91%	1,059,066 $31 Million
Q4 2020 Feb 01, 2021	BUY	$26.68 - $38.23 $17.8 Million - $25.5 Million	666,437 New	666,437 $19.9 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.